Clinical trial
fMRI for the Study of Response Inhibition, and Face and Linguistic Processing in Autism
NCT00211783 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- fMRI for the Study of Response Inhibition, and Face and Linguistic Processing in Autism
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- June 30, 2012
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asperger's syndrome, autism